Your first month on Mounjaro and Wegovy: what to expect week by week

The first month is a starter-dose phase

Mounjaro and Wegovy are both weekly injectable medicines used for weight management in adults who meet clinical suitability criteria. Mounjaro contains tirzepatide. It acts on GIP and GLP-1 receptor pathways and helps regulate appetite, fullness and cravings. Wegovy contains semaglutide, a GLP-1 receptor agonist that acts on appetite pathways and helps people feel fuller and less hungry. [1][3]

The important point for the first month is dose. Mounjaro starts at 2.5 mg once a week for four weeks before moving to 5 mg if your prescriber decides it is appropriate. Wegovy starts at 0.25 mg once a week for four weeks before moving to 0.5 mg. These low starting doses are used to reduce the likelihood of side effects while your body adapts. [1][3][4]

That means the first month should not be judged as the full test of either medicine. It is a settling-in period: learning the injection routine, noticing appetite changes, checking tolerability and building the habits that make treatment easier to continue.

Mounjaro vs Wegovy in the first month

People often try to judge the two medicines against each other after one or two injections. That is usually too early. First-month results are influenced by starting dose, side effects, bowel changes, starting weight, diet pattern, other medicines, sleep, alcohol, activity and individual biology. A slow first month does not automatically mean the medicine is wrong for you.

Week 1: first injection and early appetite changes

In week 1, most people are learning the practical routine: choosing an injection day, using the pen correctly, rotating injection sites and paying attention to how their appetite changes. Mounjaro and Wegovy can be used at any time of day, with or without meals, and are usually taken on the same day each week. [1][3]

Some people notice reduced hunger or earlier fullness within the first few days. Others feel very little at first. Both patterns can be normal. A low starting dose is not a failure; it is part of the planned escalation schedule.

Digestive symptoms can also start early. Nausea, diarrhoea, constipation, vomiting, stomach discomfort, bloating, reflux or tiredness may appear as your body adapts. Mild symptoms that improve are usually managed by smaller meals, fluids and simpler food choices. Severe or persistent symptoms need prescriber advice, especially if you cannot keep fluids down. [1][3][5]

Week 2: your routine starts to settle

By week 2, the injection routine should feel less unfamiliar. Appetite may be lower, portions may naturally shrink, and some people notice fewer cravings or less grazing between meals. The change can be subtle. You may not feel dramatically different, especially if you are expecting an immediate loss of appetite.

The main job in week 2 is observation. Track your injection day, side effects, bowel pattern, hydration, appetite, weight and any symptoms that feel unusual for you. This is more useful than trying to force a result by eating too little. Over-restriction can make nausea, constipation, tiredness and poor adherence worse.

Week 3: some people see weight loss, others do not

Week 3 is when some people start seeing a clearer scale trend, but it is still normal for weight loss to be small or inconsistent. The starting dose is still low. For some people, the main sign that treatment is beginning to work is not a dramatic weight drop but a change in behaviour: smaller meals, less snacking, feeling satisfied sooner, or thinking about food less often.

If your weight has not changed, check the context before assuming the medicine is not working. Constipation can increase scale weight. A salty meal can temporarily increase water weight. Menstrual cycle changes can mask progress. If you are eating very little protein, drinking little fluid or avoiding movement because you feel unwell, the early pattern can become harder to interpret.

Week 4: review tolerability before the next dose step

Week 4 is the final week of the starting dose for most people. Mounjaro is usually increased after four weeks from 2.5 mg to 5 mg once weekly. Wegovy is usually increased after four weeks from 0.25 mg to 0.5 mg once weekly. The decision should be based on your prescription plan and how well you have tolerated treatment. [1][3][4]

Do not treat week 4 as a pass-or-fail weigh-in. It is a checkpoint. If side effects have been mild and you are following the prescribed schedule, your prescriber may continue escalation. If side effects are significant, persistent or affecting daily life, your prescriber may advise a different approach. With Wegovy, the product information specifically allows consideration of delaying escalation or lowering to the previous dose if significant gastrointestinal symptoms occur. [4]

How quickly does Mounjaro start working?

Mounjaro can start affecting appetite before obvious weight loss appears, but there is no fixed day when it 'starts working' for everyone. Some people notice appetite suppression in week 1. Others do not notice much until the dose increases. Because the first month is spent on 2.5 mg, which is the initiation dose, early weight loss can be limited.

A practical way to judge early response is to look beyond one weigh-in. Ask: are portions smaller, is fullness lasting longer, are cravings reduced, are side effects manageable, and is weight trending down over several weeks? If the answer is still unclear after the starter phase, discuss it with your prescriber rather than changing dose yourself.

How quickly does Wegovy start working?

Wegovy can also affect appetite before weight loss becomes obvious. The first four weeks are spent on 0.25 mg once weekly, then the dose usually increases gradually every four weeks. The standard escalation schedule reaches 2.4 mg from week 17. [3][4] That staged build-up is one reason first-month Wegovy results vary. Some people see early progress. Others need more time before the combination of appetite control, portion change and the dose schedule produces a clearer trend.

What results are realistic in the first month?

A realistic first month is not the same as a dramatic first month. The target is usually to tolerate the medicine, take it correctly and begin changing the eating pattern that drives calorie intake. Weight loss may happen, but the first month is not where the full clinical effect is expected.

You may lose weight in the first month if appetite falls quickly and your food intake naturally reduces. You may lose very little if side effects affect your eating pattern, if constipation masks scale change, if you are still adapting to the medicine, or if your baseline diet already changed before treatment started. You may even see a temporary gain in week 1. That can happen from fluid, bowel changes or ordinary weight variation; it does not automatically mean fat gain.

The more useful measure is trend. Weigh under similar conditions, do not weigh repeatedly through the day, and compare several weeks rather than one reading. If weight is rising consistently, side effects are interfering with eating or drinking, or you feel the medicine is not affecting appetite after the starter phase, speak to your prescriber.

Side effects in the first month: normal, prescriber review or urgent help

The most common early side effects are digestive. The MHRA warns that nausea, vomiting and diarrhoea can sometimes lead to severe dehydration and hospital treatment, and that severe stomach pain radiating to the back can be a warning sign of acute pancreatitis. [5][6]

If you have diabetes and use insulin or a sulfonylurea, low blood sugar risk may be higher with GLP-1 treatment. Symptoms can include sweating, shaking, hunger, weakness, confusion, fast heartbeat or drowsiness. Your prescriber may need to adjust diabetes medicines and advise you on monitoring. [1][3][4]

First-month safety checks that are easy to miss

Before or during the first month, tell your prescriber if you are pregnant, planning a pregnancy, breastfeeding, using contraception, taking diabetes medicines, or due to have surgery or a procedure involving anaesthesia or deep sedation. These details can change the safest way to use treatment. [1][2][3][5]

Mounjaro should not be used during pregnancy. If you use oral contraceptives and have obesity or overweight, the Mounjaro leaflet advises considering a barrier method, such as a condom, or switching to a non-oral contraceptive method for four weeks after starting

Mounjaro and for four weeks after each dose increase. [1] Wegovy should not be used during pregnancy, and the patient leaflet advises stopping it at least two months before a planned pregnancy. If you become pregnant, think you may be pregnant, or plan to become pregnant while using Wegovy, speak to your doctor straight away because treatment will need to be stopped. [3]

Both medicines can affect digestion and gastric emptying. If you are due to have surgery or anaesthesia, tell the healthcare team that you are using Mounjaro or Wegovy. [1][2][3]

What to eat in the first month

Food advice during the first month should make treatment easier to tolerate. It should not be used to punish yourself into faster results. The aim is steady, manageable structure.

• Eat smaller meals if fullness arrives quickly.
• Prioritise protein at meals, such as eggs, fish, lean meat, Greek yoghurt, tofu, beans or pulses, depending on what suits you.
• Use fibre gradually rather than suddenly increasing it, especially if constipation is already a problem.
• Drink regularly through the day. This matters more if you have nausea, vomiting, diarrhoea or constipation.
• Go easy on very greasy, very rich or very large meals, which can worsen nausea or reflux for some people.
• Do not deliberately skip fluids or meals to chase faster weight loss. That can increase side effects and make treatment harder to continue.

If side effects are making it difficult to eat or drink, the priority is clinical advice, not pushing through. Persistent vomiting, diarrhoea, dizziness, dehydration symptoms or severe constipation should be raised with your prescriber.

What if you miss a dose in the first month?

Follow the instructions for the medicine you have been prescribed, because Mounjaro and Wegovy have different missed-dose windows.

If you are unsure what to do, ask your prescriber or pharmacist. Do not restart after a long break, increase the dose early, or switch medicine without medical advice.

Should early results decide whether you stay on Mounjaro or Wegovy?

Usually, no. The first month is too early to judge long-term suitability by weight loss alone. A prescriber will usually look at several factors: appetite response, side effects, safety issues, your medical history, other medicines, adherence, dose stage and whether the medicine remains suitable for you.

Do not switch between GLP-1 medicines on your own. The MHRA advises speaking to a healthcare professional before switching because GLP-1 medicines differ in strength, use and licensed indications, and switching without advice may increase side effects or reduce effectiveness. [5]